Drug General Information
Drug ID	D0G5TL
Former ID	DNC007087
Drug Name	6-hydroxy-1,2,9-trimethyl-9H-beta-carbolin-2-ium
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528415]
Structure		Download 2D MOL 3D MOL
Formula	C14H15N2O+
Canonical SMILES	CC1=[N+](C=CC2=C1N(C3=C2C=C(C=C3)O)C)C
InChI	1S/C14H14N2O/c1-9-14-11(6-7-15(9)2)12-8-10(17)4-5-13(12)16(14)3/h4-8H,1-3H3/p+1
InChIKey	CHMZSXAIQRLCLX-UHFFFAOYSA-O
PubChem Compound ID	44419706
Target and Pathway
Target(s)	Acetylcholinesterase	Target Info	Inhibitor	[528415]
	Cholinesterase	Target Info	Inhibitor	[528415]
KEGG Pathway	Glycerophospholipid metabolism
	Cholinergic synapse
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
PathWhiz Pathway	Phospholipid Biosynthesis
WikiPathways	Monoamine Transport
	Biogenic Amine Synthesis
	Acetylcholine Synthesis
	Integrated Pancreatic Cancer PathwayWP229:Irinotecan Pathway
References
Ref 528415	Bioorg Med Chem Lett. 2006 Nov 15;16(22):5840-3. Epub 2006 Sep 1.6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
Ref 528415	Bioorg Med Chem Lett. 2006 Nov 15;16(22):5840-3. Epub 2006 Sep 1.6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.